Home »
Academic Articles & Research Papers
Showing 20 of 81 academic articles
Jang S, Chen J • Innovation in aging
(2026)
PMC
PMC Public Access (View-Only)
DOI: 10.1093/geroni/igag085
PMC: PMC13602412
Popp Z, James A, Chivardi M, Reimer CJ et al. • Alzheimer's & dementia : the journal of the Alzheimer's Association
(2026)
PMC
PMC Public Access (View-Only)
DOI: 10.1002/alz.71841
PMC: PMC13619739
Li C, Zhao C, Lan Y, Ellis RJ et al. • Alzheimer's & dementia : the journal of the Alzheimer's Association
(2026)
PMC
PMC Public Access (View-Only)
DOI: 10.1002/alz.71842
PMC: PMC13624529
Chapel JM, Tysinger B, Pourmand H, Goldman D et al. • Alzheimer's & dementia : the journal of the Alzheimer's Association
(2026)
PMC
PMC Public Access (View-Only)
DOI: 10.1002/alz.71819
PMC: PMC13643942
Moughamian AJ, La Vallee L, Kile S, Urban T et al. • Alzheimer's & dementia (Amsterdam, Netherlands)
(2026)
PMC
PMC Public Access (View-Only)
DOI: 10.1002/dad2.70479
PMC: PMC13651009
Kamalakar K, Akerele C, Lafont E, Koralnik LR et al. • Nutrients
(2026)
PMC
PMC Public Access (View-Only)
DOI: 10.3390/nu18193146
PMC: PMC13666574
Torres-Cintrón M, Mendoza-Graf A, Castro G, Ramos-Valencia G et al. • Frontiers in public health
(2026)
PMC
PMC Public Access (View-Only)
DOI: 10.3389/fpubh.2026.1923342
PMC: PMC13687668
Benussi A, Agosta F, Agnello L, Alfano AR et al. • The journal of prevention of Alzheimer's disease
(2026)
PMC
PMC Public Access (View-Only)
DOI: 10.1016/j.tjpad.2026.100685
PMC: PMC13693314
Liu Y, Feng X, Dong H, Lan T et al. • Microorganisms
(2026)
PMC
PMC Public Access (View-Only)
DOI: 10.3390/microorganisms14102157
PMC: PMC13707487
Islam N, Foroutan F, Johnson TM 2nd, Smith AG et al. • BMJ open
(2026)
PMC
PMC Public Access (View-Only)
DOI: 10.1136/bmjopen-2026-121221
PMC: PMC13723828
Jacquier-Sarlin M, Seignobos M, Rauzier L, Schaack B et al. • Frontiers in neuroscience
(2026)
PMC
PMC Public Access (View-Only)
DOI: 10.3389/fnins.2026.1963040
PMC: PMC13725227
Chakravarthy A • Frontiers in aging neuroscience
(2026)
PMC
PMC Public Access (View-Only)
DOI: 10.3389/fnagi.2026.1918251
PMC: PMC13736582
Bienvenido Rodríguez-Lezcano, Doris Jeanlouis, Daniella Agnes Malulu, Carmen Vázquez-Lazo • Revista Electrónica Dr. Zoilo E. Marinello Vidaurreta
(2023)
Background: dementia has now become a major cause of death, leading to disability and dependence.
Objective: to characterize clinical and epidemiological variables in patients with dementia in Seychelles, from July 2018 to August 2019.
Me...
DOAJ
Open Access (DOAJ)
Lin-lin Yao, Xiao-ting Ma, Fang-bo Li, Lin-yi Zheng et al. • Experimental Gerontology
(2026)
Background: Alzheimer's disease (AD) is a neurodegenerative disorder primarily characterized by cognitive dysfunction. The discovery and identification of non-cognitive symptoms in the preclinical stage hold promise for early diagnosis and ...
DOAJ
Open Access (DOAJ)
DOI: 10.1016/j.exger.2026.113057
Meng Zhang, Ping He, Zhigang Bian • Frontiers in Molecular Neuroscience
(2021)
Neurodegenerative diseases (NDDs), including Alzheimer’s disease (AD), Parkinson’s disease (PD), Huntington’s disease (HD), and amyotrophic lateral sclerosis (ALS), are progressive and ultimately fatal. NDD onset is influenced by several fa...
DOAJ
Open Access (DOAJ)
DOI: 10.3389/fnmol.2021.685143
Eimear Connolly, Shane Lyons, Cliona O’Farrelly, Graham Knight et al. • BMJ Open
(2023)
Introduction Alzheimer’s disease and other dementias affect >50 million individuals globally and are characterised by broad clinical and biological heterogeneity. Cohort and biobank studies have played a critical role in advancing the un...
DOAJ
Open Access (DOAJ)
DOI: 10.1136/bmjopen-2023-077772
Erden Eren, Jeannie-Marie Leoutsakos, Juan Troncoso, Constantine G. Lyketsos et al. • Cells
(2022)
The hallmarks of Alzheimer’s disease (AD) pathology are senile plaques containing amyloid-beta (Aβ) and neurofibrillary tangles containing hyperphosphorylated tau. Additional pathologies often co-exist, whereas multiple pathogenic mechanism...
DOAJ
Open Access (DOAJ)
DOI: 10.3390/cells11030436
Anna Pratima Nikalje • Medicinal Chemistry
(2015)
Nanotechnologyis the study of extremely small structures, having size of 0.1 to 100 nm. Nano medicine is a relatively new field of science and technology. Brief explanation of various types of pharmaceutical nano systems is given. Classific...
OPENALEX
DOI: https://doi.org/10.4172/2161-0444.1000247
Sebastian Crutch, Claire Waddington, Emma Harding, Emilie Brotherhood et al. • General Psychiatry
(2025)
Rarer dementias are associated with atypical symptoms and younger onset, which result in a higher burden of care. We provide a review of the global literature on longitudinal decline in activities of daily living (ADLs) in dementias that ac...
DOAJ
Open Access (DOAJ)
DOI: 10.1136/gpsych-2024-101905
Sofia Leonardo, Felipe Fregni • Frontiers in Aging Neuroscience
(2023)
BackgroundThe development of mild cognitive impairment (MCI) and Alzheimer’s disease (AD) may be associated with an inflammatory process. Inflammatory cytokines may be a surrogate for systemic inflammation leading to worsening neurological ...
DOAJ
Open Access (DOAJ)
DOI: 10.3389/fnagi.2023.1069439